Please assess the completion status of the following clinical trial:

Trial Title: ENDObesity® II Study: TransPyloric Shuttle® System for Weight Loss

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female subjects between the ages of 22 to 60~* A BMI between 30.0 to 40.0 kg/m2, inclusive. Subjects with a BMI of 30.0 kg/m2 to 34.9 kg/m2 are required to have one or more obesity-related comorbidities~* History of obesity for at least 2 years, with history of failure of medically or commercially supervised weight loss program~* \< 5% change in body weight for at least 3 months~* Negative pregnancy test, agree to be on birth control for the duration of participation~* Informed consent~* Willing and able to comply with study procedures~Exclusion Criteria:~* Pregnancy or nursing~* Hormonal or genetic cause for obesity~* Prior history of any GI surgery or endoscopic intervention~* Chronic use of medications likely to contribute to weight gain or prevent weight loss~* Gastric or duodenal ulcers~* Positive for H. pylori~* History of severe dyspepsia~* GI tract motility disorders~* History of inflammatory disease of GI tract, coeliac disease, pancreatitis, portal hypertension, cirrhosis, and/or varices~* Diabetes treated with insulin~* HbA1c \>7.5%~* Uncontrolled thyroid and adrenal gland disease or uncontrolled hypertension~* History of certain cardiac events~* Localized or systemic infection~* Anemia~* History of asthma likely to require systemic steroid therapy~* Autoimmune connective tissue disorders or immunocompromised~* History of malignancy except non-melanoma skin cancer~* Continuous use of ulcerogenic medication~* On anticoagulation or antiplatelet therapy~* Use of weight-loss medication~* In other weight-loss program~* Unable to take proton pump inhibitor~* Abnormal laboratory values or EKG~* Inability to walk at least 0.8 kilometers per day~* Planned surgical procedure that can impact the conduct of the study~* Known allergy to any component materials in the TPSS~* Smoker or user of nicotine product~* Substance abuse~* Severe, uncontrolled psychiatric illness~* Recent inpatient psychiatric treatment~* Moderate depression~* Bulimia nervosa or binge eating disorder~* Participation in another clinical study~* Employee or family member of Sponsor or study staff~* Have any endoscopic exclusion criteria

- Gender: ALL
- Minimum Age: 22 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- TransPyloric Shuttle (TPS) (Type: EXPERIMENTAL): TransPyloric Shuttle plus Lifestyle Counseling
- Control (Type: SHAM_COMPARATOR): Sham procedure plus Lifestyle Counseling

Based on this trial design, predict the completion outcome and termination type (if applicable).